Granules Intrinsic Value
GRANULES • Healthcare
Current Stock Price
₹613.60
Primary Intrinsic Value
₹473.44
Market Cap
₹1473 Cr
+100.0%
Upside
Median Value
₹1227.20
Value Range
₹184 - ₹1534
Assessment
Trading Below Calculated Value
Safety Margin
50.0%
GRANULES Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹473.44 | ₹378.75 - ₹568.13 | -22.8% | EPS: ₹21.52, Sector P/E: 22x |
| Book Value Method | asset | ₹1534.00 | ₹1380.60 - ₹1687.40 | +150.0% | Book Value/Share: ₹1548.33, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹1227.20 | ₹1104.48 - ₹1349.92 | +100.0% | Revenue/Share: ₹2156.67, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹1227.20 | ₹1104.48 - ₹1349.92 | +100.0% | EBITDA: ₹1100.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹1534.00 | ₹1227.20 - ₹1840.80 | +150.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹184.08 | ₹165.67 - ₹202.49 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹332.48 | ₹299.23 - ₹365.73 | -45.8% | Revenue Growth: 6.0%, Adj P/E: 15.5x |
| ROE Based Valuation | profitability | ₹1227.20 | ₹1104.48 - ₹1349.92 | +100.0% | ROE: 14.1%, P/E Multiple: 12x |
| Graham Defensive Method | conservative | ₹865.85 | ₹779.26 - ₹952.44 | +41.1% | EPS: ₹21.52, BVPS: ₹1548.33 |
Method Types:
Earnings
Asset
DCF
Growth
Dividend
Conservative
Valuation Comparison Chart
GRANULES Intrinsic Value Analysis
What is the intrinsic value of GRANULES?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Granules (GRANULES) is ₹1227.20 (median value). With the current market price of ₹613.60, this represents a +100.0% variance from our estimated fair value.
The valuation range spans from ₹184.08 to ₹1534.00, indicating ₹184.08 - ₹1534.00.
Is GRANULES undervalued or overvalued?
Based on our multi-method analysis, Granules (GRANULES) appears to be trading below calculated value by approximately 100.0%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 5.84 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 14.1% | Industry Standard: 15%+ | Above 10% | Measures shareholder return efficiency |
| Operating Margin | 21.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.83x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
Related Pages for Granules
Additional stock information and data for GRANULES
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹867 Cr | ₹523 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹439 Cr | ₹260 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹739 Cr | ₹643 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹332 Cr | ₹143 Cr | Positive Free Cash Flow | 7/10 |
| March 2021 | ₹433 Cr | ₹295 Cr | Positive Free Cash Flow | 8/10 |